2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (Feno) in asthma management
Gespeichert in:
| Veröffentlicht in: | Journal of allergy and clinical immunology 2020-12, Vol.146 (6), p.1281-1282 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1282 |
|---|---|
| container_issue | 6 |
| container_start_page | 1281 |
| container_title | Journal of allergy and clinical immunology |
| container_volume | 146 |
| creator | Lipworth, Brian Kuo, Chris RuiWen Chan, Rory |
| description | |
| doi_str_mv | 10.1016/j.jaci.2020.03.006 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2467841623</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674920304073</els_id><sourcerecordid>2467841623</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-8b001b7844d0f1500db5c8df5a4113baa4afa38e9be31ef5f179e9980d5d252d3</originalsourceid><addsrcrecordid>eNp9kD1rHDEQhoVJsC-2_0CKoNIpdjOS9jOkMUfsBAxp4lpopVGsY1e6SFpj__voOMelq2GG93lgXkI-MqgZsO7Lrt4p7WoOHGoQNUB3QjYMxr7qBt6-IxuAkVVd34xn5ENKOyi7GMZTciYEH6BnbEPCgab3e6MyGnqd8sOi6O3qDM7OY_pKt2U6rWa6Zje7_EyDpTYqnV3w5YpPD2oupHc5Ok3DUyHp1Q368Jk6T9VRuCiv_uCCPl-Q91bNCS9f5jm5v_n-e_ujuvt1-3N7fVfpBiBXwwTApn5oGgOWtQBmavVgbKsaxsSkVKOsEgOOEwqGtrWsH3EcBzCt4S034pxcHb37GP6umLJcXNI4z8pjWJPkTVfsrOOiRPkxqmNIKaKV--gWFZ8lA3koWu7koWh5qEqCkKXoAn168a_TguYV-d9sCXw7BrB8-egwyqQdeo3GRdRZmuDe8v8Dz9iOsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2467841623</pqid></control><display><type>article</type><title>2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (Feno) in asthma management</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Lipworth, Brian ; Kuo, Chris RuiWen ; Chan, Rory</creator><creatorcontrib>Lipworth, Brian ; Kuo, Chris RuiWen ; Chan, Rory</creatorcontrib><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2020.03.006</identifier><identifier>PMID: 33280711</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Asthma ; Asthma - diagnosis ; Asthma - drug therapy ; Exhalation ; fractional exhaled nitric oxide ; Humans ; IL-13 ; inhaled corticosteroid ; Nitric Oxide ; type 2 inflammation</subject><ispartof>Journal of allergy and clinical immunology, 2020-12, Vol.146 (6), p.1281-1282</ispartof><rights>2020 American Academy of Allergy, Asthma & Immunology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-8b001b7844d0f1500db5c8df5a4113baa4afa38e9be31ef5f179e9980d5d252d3</citedby><cites>FETCH-LOGICAL-c400t-8b001b7844d0f1500db5c8df5a4113baa4afa38e9be31ef5f179e9980d5d252d3</cites><orcidid>0000-0002-8140-2014</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2020.03.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33280711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lipworth, Brian</creatorcontrib><creatorcontrib>Kuo, Chris RuiWen</creatorcontrib><creatorcontrib>Chan, Rory</creatorcontrib><title>2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (Feno) in asthma management</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><subject>Asthma</subject><subject>Asthma - diagnosis</subject><subject>Asthma - drug therapy</subject><subject>Exhalation</subject><subject>fractional exhaled nitric oxide</subject><subject>Humans</subject><subject>IL-13</subject><subject>inhaled corticosteroid</subject><subject>Nitric Oxide</subject><subject>type 2 inflammation</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kD1rHDEQhoVJsC-2_0CKoNIpdjOS9jOkMUfsBAxp4lpopVGsY1e6SFpj__voOMelq2GG93lgXkI-MqgZsO7Lrt4p7WoOHGoQNUB3QjYMxr7qBt6-IxuAkVVd34xn5ENKOyi7GMZTciYEH6BnbEPCgab3e6MyGnqd8sOi6O3qDM7OY_pKt2U6rWa6Zje7_EyDpTYqnV3w5YpPD2oupHc5Ok3DUyHp1Q368Jk6T9VRuCiv_uCCPl-Q91bNCS9f5jm5v_n-e_ujuvt1-3N7fVfpBiBXwwTApn5oGgOWtQBmavVgbKsaxsSkVKOsEgOOEwqGtrWsH3EcBzCt4S034pxcHb37GP6umLJcXNI4z8pjWJPkTVfsrOOiRPkxqmNIKaKV--gWFZ8lA3koWu7koWh5qEqCkKXoAn168a_TguYV-d9sCXw7BrB8-egwyqQdeo3GRdRZmuDe8v8Dz9iOsw</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Lipworth, Brian</creator><creator>Kuo, Chris RuiWen</creator><creator>Chan, Rory</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8140-2014</orcidid></search><sort><creationdate>202012</creationdate><title>2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (Feno) in asthma management</title><author>Lipworth, Brian ; Kuo, Chris RuiWen ; Chan, Rory</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-8b001b7844d0f1500db5c8df5a4113baa4afa38e9be31ef5f179e9980d5d252d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Asthma</topic><topic>Asthma - diagnosis</topic><topic>Asthma - drug therapy</topic><topic>Exhalation</topic><topic>fractional exhaled nitric oxide</topic><topic>Humans</topic><topic>IL-13</topic><topic>inhaled corticosteroid</topic><topic>Nitric Oxide</topic><topic>type 2 inflammation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lipworth, Brian</creatorcontrib><creatorcontrib>Kuo, Chris RuiWen</creatorcontrib><creatorcontrib>Chan, Rory</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lipworth, Brian</au><au>Kuo, Chris RuiWen</au><au>Chan, Rory</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (Feno) in asthma management</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2020-12</date><risdate>2020</risdate><volume>146</volume><issue>6</issue><spage>1281</spage><epage>1282</epage><pages>1281-1282</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33280711</pmid><doi>10.1016/j.jaci.2020.03.006</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-8140-2014</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0091-6749 |
| ispartof | Journal of allergy and clinical immunology, 2020-12, Vol.146 (6), p.1281-1282 |
| issn | 0091-6749 1097-6825 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2467841623 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
| subjects | Asthma Asthma - diagnosis Asthma - drug therapy Exhalation fractional exhaled nitric oxide Humans IL-13 inhaled corticosteroid Nitric Oxide type 2 inflammation |
| title | 2020 Updated Asthma Guidelines: Clinical utility of fractional exhaled nitric oxide (Feno) in asthma management |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T07%3A40%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2020%20Updated%20Asthma%20Guidelines:%20Clinical%20utility%20of%20fractional%20exhaled%20nitric%20oxide%20(Feno)%20in%20asthma%20management&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Lipworth,%20Brian&rft.date=2020-12&rft.volume=146&rft.issue=6&rft.spage=1281&rft.epage=1282&rft.pages=1281-1282&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2020.03.006&rft_dat=%3Cproquest_cross%3E2467841623%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2467841623&rft_id=info:pmid/33280711&rft_els_id=S0091674920304073&rfr_iscdi=true |